Using antibiotics in case of influenza;Utilisation des antibiotiques au cours de la grippe

Medecine et Maladies Infectieuses

Volumn 36, Issue 4, 2006, Pages 181-189

  Chidiac, C ^a   Maulin, L ^a  

^a CROIX ROUSSE HOSPITAL   (France)

Author keywords

Bacterial infection; Influenza; Neuraminidase inhibitor; Pneumonia

Indexed keywords

ANTIBIOTIC AGENT; SIALIDASE INHIBITOR; ANTIINFECTIVE AGENT; SIALIDASE;

ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COMORBIDITY; DEATH; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; INFLUENZA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTPATIENT; PNEUMONIA; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; BACTERIAL PNEUMONIA; BRONCHITIS; CHILD; DISEASE PREDISPOSITION; DRUG ANTAGONISM; FEMALE; GRAM NEGATIVE INFECTION; INFANT; MALE; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; REVIEW; SINUSITIS; SUPPURATIVE OTITIS MEDIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BRONCHITIS; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEURAMINIDASE; OTITIS MEDIA, SUPPURATIVE; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS; SINUSITIS;

EID: 33646476129     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.12.008     Document Type: Article

References (50)

1. Simonsen L., Fukuda K., Schonberger L.B., and Cox N.J. The impact of influenza epidemics on hospitalisations. J. Infect. Dis. 181 (2000) 831-837
2. Manuguerra JC. Grippe. Encyclop. Méd. Chir. (Éditions Scientifiques et Médicales Elsevier SAS, Paris), maladies infectieuses, 8-069-A-10, 2002, 22p.
3. Nicholson K.G. In: Nicholson K.G., Webster R.G., and Hay A.J. (Eds). Textbook of influenza (1998), Blackwell Science, London 219-264
4. Monto A.S., Flemmeing D.M., Henry D., de Groot R., Makela M., Klein T., et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J. Infec. Dis. 180 (1999) 254-261
5. Kaiser L., Keene O.N., Hammond M.J., Elliott M., and Hayde F.G. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Arch. Intern. Med. 160 (2000) 3234-3240
6. Treanor J.J., Hyden F.H., Vrooman P.S., Barbarash, Bettis R., Riff D., et al. Efficacy ans safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. A randomized controlled trial. JAMA 283 (2000) 1016-1024
7. Kaiser L., Wat C., Mills T., Mahoney P., Ward P., and Hayde F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch. Intern. Med. 163 (2003) 1667-1672
8. Peters P.H., Gravenstein S., Norwood P., De Boeck V., Van Couter A., Gibbens M., et al. Long-term use of oseltamivir fro the prophylaxis of influenza in a vaccinated frail older population. J. Am. Geriatr. Soc. 49 (2001) 1025-1031
9. Meier C.R., Napalkov P.N., Wegmüller Y., Jefferson T., and Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur. J. Clin. Microb. Infect. Dis. 19 (2000) 834-842
10. Carilli A.D., Gohd R.S., and Gordon W. A virologic study of chronic bronchitis. N. Engl. J. Med. 270 (1964) 123-127
11. Ferson M.J., Morton J.R., and Robertson P.W. Impact of influenza on morbidity in children with cystic fibrosis. J. Paedtr. Child. Health. 27 (1991) 308-311
12. Minor M.E., Dick E.C., Backer J.W., Ouellette J.J., Cohen M., and Reed C.E. Rhinovirus and influenza A infections as precipitants of asthma. Am. Rev. Respir. Dis. 113 (1976) 149-153
13. Cox N.J., and Subbaro K. Influenza. Lancet 354 (1999) 1277-1282
14. Sethi S. Bacterial pneumonia managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics 57 (2002) 56-61
15. Cesario T., and Yousefi S. Viral infections. Clin. Geriatr. Med. 8 (1992) 735-743
16. Patriarca P., Weber J., and Parker R. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 1136-1139
17. Gaydos J.C., Hodder R.A., and Top F.H. Swine influenza A at Fort Dix New Jersey. Case finding and study of cases. J. Infect. Dis. 136S (1997) 356-362
18. Upshur R.E., Knight K., and Goel V. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure. Am. J. Epidemiol. 149 (2000) 85-92
19. e édition traduite en français) (1993), Flammarion Médecine Sciences, Paris 695-700
20. Hosker H., Jones G., and Hawkey P. Management of community acquired lower respiratory tract infection. BMJ 308 (1994) 701-705
21. Louria D.B., Bluemenfeld H.L., Ellis J.T., et al. Studies of influenza in the pandemic of 1957-1958. II. Pulmonatry complications of influenza. J. Clin. Invest. 38 (1959) 213-265
22. Schwarzmann S.W., Adler J.L., Sullivan R.J., and Marine W.M. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch. Intern. Med. 127 (1971) 1037-1041
23. Oliveira E.C., Marik P.E., and Colice G. Influenza pneumonia. A descriptive study. Chest 119 (2001) 1717-1723
24. Barker W.H., and Mullooly J.P. Pneumonia and influenza deaths during epidemics: Implications for prevention. Arch. Intern. Med. 142 (1982) 85-89
25. Ruuskenen O., Arola M., Putto-Laurila A., Mertsola J., Meusman O., Viljanen M.K., et al. Acute otitis media and respiratory virus infection. Pediatr. Infect. Dis. 8 (1989) 94-99
26. Henderson F., Collier A., Sanyal M., et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N. Engl. J. Med. 306 (1982) 1377-1383
27. Whitley R.J., Hayden F.G., Reisinger K.S., Young N., Dutkowski R., Ipe D., et al. Oral oseltamivir treatment of influenza in children. Pediatr. Infect. Dis. J. 20 (2001) 127-133
28. Heikkinen T., Thint M., and Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N. Engl. J. Med. 340 (1999) 260-264
29. e ICID avril 2000 ; Buenos Aires.
30. GROG. Données non publiées.
31. Pappo M. Données non publiées.
32. VIGIGRIP. Données non publiées.
33. Vetel J.M., Allaert F.A., Cohen J.M., Huas D., Mosnier A., Pouchain D., et al. Rev. Geriatr. 27 (2002) 183-188
34. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., and Griffin M.R. Effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med. 342 (2000) 225-231
35. Jones A., Mac Farlane J., and Pugh S. Antibiotic therapy, clinical features and outcome of 36 adults presenting to hospital with proven influenza, do we follow guidelines?. Postgrad. Med. J. 67 (1991) 988-990
36. Maeda S., Yamada Y., Nakamura H., and Maeda T. Efficacy of antibiotics against influenza-like illness in an influenza epidemic. Pediatr. Int. 41 (1999) 274-276
37. Carrat F, Schwarzingzr M, Housset B, Valleron AJ. Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays. Soumis pour publication.
38. Fahey T., Stocks N., and Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 316 (1998) 906-910
39. e Conférence de Consensus en thérapeutique anti-infectieuse de la société de pathologie infectieuse de langue française (SPILF). Prise en charge des infections des voies respiratoires basses. Med. Mal. Infect. 2001; 30 : 568-80. Site Internet : http://www.infectiologie.com/public/documents/consensus/pdf/vri-2000.PDF .
40. Chidiac C. De la résistance à l'échec clinique : quelle réalité dans les pneumonies communautaires ?. In: Gehanno P., Léophonte P., and Mouton Y. (Eds). Infections respiratoires : les résistances bactériennes en pratique clinique (2001), EDK ed., Paris 67-79
41. Chidiac C. Nouvelles fluoroquinolones et pneumonies aiguës communautaires (PAC). Lettre Infectiol. 17 (2002) 95-98
42. Ketek RCP. (télithromycine). Résumé des caractéristiques du produit http://www.eudra.org/humandocs/Humans/EPAR/ketek/ketek.htm.
43. RCP Zyvoxid (linézolide). Résumé des caractéristiques du produit.
44. Afssaps. Antibiothérapie par voie générale en pratique courante : exacerbations de bronchite chronique : recommandations juillet 2001. Site Internet : http://afssaps.sante.fr/htm/11/11000.htm.
45. SPLF. Actualisation des recommandations de la SPLF pour la prise en charge des BPCO. 2003.
46. Afssaps. Antibiothérapie par voie générale en pratique courante : infections ORL et respiratoires basses. Réactualisation 2002. Site Internet : http://afssaps.sante.fr/htm/11/11000.htm.
47. Monto A.S., Webster A., and Keene O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J. Antimicrob. Chemother. 44 (1999) 23-29 (B)
48. Afssaps : antibiothérapie par voie générale en pratique courante : sinusites aiguës de l'adulte. Recommandations.
49. Afssaps : antibiothérapie par voie générale en pratique courante : otite moyenne aiguë. Recommandations.
50. Mouton Y., and et le groupe de travail « grippe ». Recommandations du Groupe de travail « grippe » face à une pandémie grippale due à un virus non inclus dans le vaccin. Rapport d'experts. Med. Mal. Inf. 30 (2000) 71-79